Predict your next investment

HEALTHCARE | Elective & Aesthetic Medicine

See what CB Insights has to offer

Founded Year

2005

Stage

Acquired | Acquired

Total Raised

$8.4M

About ForSight VISION4

ForSight Labs is a community of ophthalmic innovation focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients.

ForSight VISION4 Headquarter Location

191 Jefferson Drive

Menlo Park, California, 94025,

United States

650-325-2050

Latest ForSight VISION4 News

ForSight VISION4, Inc. Announces Acquisition by Roche

Jan 16, 2017

Announces Acquisition by Roche Next Story Prev Story 1 hr ago Read more: Vision Monday MENLO PARK, Calif.-ForSight VISION4, a privately held biotechnology company innovating drug delivery for treatment of retinal diseases, announced that it has been acquired by Roche Holdings Inc. The company is the fourth venture created by the Menlo Park incubator, ForSight Labs, LLC , and was funded entirely by two of the leading venture capital firms in Silicon Valley, Morgenthaler Ventures and Versant Ventures. The acquisition expands Roche's exclusive access to the ForSight VISION4 PDS technology for long acting delivery of therapeutics to the eye. Start the conversation, or Read more at Vision Monday.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ForSight VISION4 Patents

ForSight VISION4 has filed 63 patents.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Ophthalmology
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/1/2019

9/7/2021

Drug delivery devices, Dosage forms, Transcription factors, Diseases of the eye and adnexa, Medical equipment

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/1/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/7/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Drug delivery devices, Dosage forms, Transcription factors, Diseases of the eye and adnexa, Medical equipment

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.